img

Global Companion Animals Medicines and Vaccines Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Companion Animals Medicines and Vaccines Market Insights, Forecast to 2034

In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
Some of the most popular companion animals are likely dogs and cats; other animals commonly kept may include pigs, red foxes, ferrets, and rabbits; rodents such as gerbils, hamsters, chinchillas, fancy rats, and guinea pigs; avian pets, such as canaries, parrots, and fowl; reptile pets, such as turtles, lizards and snakes; aquatic pets, such as fish, freshwater and saltwater aquatic snails, frogs; arthropod pets, such as tarantulas and hermit crabs, and many other species.
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
Market Analysis and InsightsGlobal Companion Animals Medicines and Vaccines Market
Global Companion Animals Medicines and Vaccines market is expected to reach to US$ 17350 million in 2024, with a positive growth of %, compared with US$ 16230 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Companion Animals Medicines and Vaccines industry is evaluated to reach US$ 24190 million in 2029. The CAGR will be 5.7% during 2024 to 2029.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Covers
This report presents an overview of global Companion Animals Medicines and Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Companion Animals Medicines and Vaccines market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Medicines
Vaccines

Segment by Application


Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Companion Animals Medicines and Vaccines introduction, etc. Companion Animals Medicines and Vaccines Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Companion Animals Medicines and Vaccines
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Medicines
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animals Medicines and Vaccines Market Perspective (2018-2029)
2.2 Global Companion Animals Medicines and Vaccines Growth Trends by Region
2.2.1 Companion Animals Medicines and Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Companion Animals Medicines and Vaccines Historic Market Size by Region (2018-2024)
2.2.3 Companion Animals Medicines and Vaccines Forecasted Market Size by Region (2024-2029)
2.3 Companion Animals Medicines and Vaccines Market Dynamics
2.3.1 Companion Animals Medicines and Vaccines Industry Trends
2.3.2 Companion Animals Medicines and Vaccines Market Drivers
2.3.3 Companion Animals Medicines and Vaccines Market Challenges
2.3.4 Companion Animals Medicines and Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Companion Animals Medicines and Vaccines by Players
3.1.1 Global Companion Animals Medicines and Vaccines Revenue by Players (2018-2024)
3.1.2 Global Companion Animals Medicines and Vaccines Revenue Market Share by Players (2018-2024)
3.2 Global Companion Animals Medicines and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Companion Animals Medicines and Vaccines, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Companion Animals Medicines and Vaccines Market Concentration Ratio
3.4.1 Global Companion Animals Medicines and Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animals Medicines and Vaccines Revenue in 2022
3.5 Global Key Players of Companion Animals Medicines and Vaccines Head office and Area Served
3.6 Global Key Players of Companion Animals Medicines and Vaccines, Product and Application
3.7 Global Key Players of Companion Animals Medicines and Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animals Medicines and Vaccines Breakdown Data by Type
4.1 Global Companion Animals Medicines and Vaccines Historic Market Size by Type (2018-2024)
4.2 Global Companion Animals Medicines and Vaccines Forecasted Market Size by Type (2024-2029)
5 Companion Animals Medicines and Vaccines Breakdown Data by Application
5.1 Global Companion Animals Medicines and Vaccines Historic Market Size by Application (2018-2024)
5.2 Global Companion Animals Medicines and Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Companion Animals Medicines and Vaccines Market Size (2018-2029)
6.2 North America Companion Animals Medicines and Vaccines Market Size by Type
6.2.1 North America Companion Animals Medicines and Vaccines Market Size by Type (2018-2024)
6.2.2 North America Companion Animals Medicines and Vaccines Market Size by Type (2024-2029)
6.2.3 North America Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
6.3 North America Companion Animals Medicines and Vaccines Market Size by Application
6.3.1 North America Companion Animals Medicines and Vaccines Market Size by Application (2018-2024)
6.3.2 North America Companion Animals Medicines and Vaccines Market Size by Application (2024-2029)
6.3.3 North America Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
6.4 North America Companion Animals Medicines and Vaccines Market Size by Country
6.4.1 North America Companion Animals Medicines and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Companion Animals Medicines and Vaccines Market Size by Country (2018-2024)
6.4.3 North America Companion Animals Medicines and Vaccines Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Companion Animals Medicines and Vaccines Market Size (2018-2029)
7.2 Europe Companion Animals Medicines and Vaccines Market Size by Type
7.2.1 Europe Companion Animals Medicines and Vaccines Market Size by Type (2018-2024)
7.2.2 Europe Companion Animals Medicines and Vaccines Market Size by Type (2024-2029)
7.2.3 Europe Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
7.3 Europe Companion Animals Medicines and Vaccines Market Size by Application
7.3.1 Europe Companion Animals Medicines and Vaccines Market Size by Application (2018-2024)
7.3.2 Europe Companion Animals Medicines and Vaccines Market Size by Application (2024-2029)
7.3.3 Europe Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
7.4 Europe Companion Animals Medicines and Vaccines Market Size by Country
7.4.1 Europe Companion Animals Medicines and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Companion Animals Medicines and Vaccines Market Size by Country (2018-2024)
7.4.3 Europe Companion Animals Medicines and Vaccines Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Companion Animals Medicines and Vaccines Market Size (2018-2029)
8.2 China Companion Animals Medicines and Vaccines Market Size by Type
8.2.1 China Companion Animals Medicines and Vaccines Market Size by Type (2018-2024)
8.2.2 China Companion Animals Medicines and Vaccines Market Size by Type (2024-2029)
8.2.3 China Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
8.3 China Companion Animals Medicines and Vaccines Market Size by Application
8.3.1 China Companion Animals Medicines and Vaccines Market Size by Application (2018-2024)
8.3.2 China Companion Animals Medicines and Vaccines Market Size by Application (2024-2029)
8.3.3 China Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Companion Animals Medicines and Vaccines Market Size (2018-2029)
9.2 Asia Companion Animals Medicines and Vaccines Market Size by Type
9.2.1 Asia Companion Animals Medicines and Vaccines Market Size by Type (2018-2024)
9.2.2 Asia Companion Animals Medicines and Vaccines Market Size by Type (2024-2029)
9.2.3 Asia Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
9.3 Asia Companion Animals Medicines and Vaccines Market Size by Application
9.3.1 Asia Companion Animals Medicines and Vaccines Market Size by Application (2018-2024)
9.3.2 Asia Companion Animals Medicines and Vaccines Market Size by Application (2024-2029)
9.3.3 Asia Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
9.4 Asia Companion Animals Medicines and Vaccines Market Size by Region
9.4.1 Asia Companion Animals Medicines and Vaccines Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Companion Animals Medicines and Vaccines Market Size by Region (2018-2024)
9.4.3 Asia Companion Animals Medicines and Vaccines Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Type
10.2.1 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Application
10.3.1 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Country
10.4.1 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animals Medicines and Vaccines Introduction
11.1.4 Zoetis Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.1.5 Zoetis Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Companion Animals Medicines and Vaccines Introduction
11.2.4 Boehringer Ingelheim Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Details
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Companion Animals Medicines and Vaccines Introduction
11.3.4 Merck Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.3.5 Merck Animal Health Recent Developments
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Details
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Companion Animals Medicines and Vaccines Introduction
11.4.4 Elanco Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.4.5 Elanco Animal Health Recent Developments
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Details
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Companion Animals Medicines and Vaccines Introduction
11.5.4 Bayer Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.5.5 Bayer Animal Health Recent Developments
11.6 Virbac
11.6.1 Virbac Company Details
11.6.2 Virbac Business Overview
11.6.3 Virbac Companion Animals Medicines and Vaccines Introduction
11.6.4 Virbac Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.6.5 Virbac Recent Developments
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Details
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Companion Animals Medicines and Vaccines Introduction
11.7.4 Dechra Veterinary Products Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.7.5 Dechra Veterinary Products Recent Developments
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Ceva Business Overview
11.8.3 Ceva Companion Animals Medicines and Vaccines Introduction
11.8.4 Ceva Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.8.5 Ceva Recent Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Companion Animals Medicines and Vaccines Introduction
11.9.4 Vetoquinol Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.9.5 Vetoquinol Recent Developments
11.10 Meiji
11.10.1 Meiji Company Details
11.10.2 Meiji Business Overview
11.10.3 Meiji Companion Animals Medicines and Vaccines Introduction
11.10.4 Meiji Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.10.5 Meiji Recent Developments
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Details
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Companion Animals Medicines and Vaccines Introduction
11.11.4 Ouro Fino Saude Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.11.5 Ouro Fino Saude Recent Developments
11.12 Parnell
11.12.1 Parnell Company Details
11.12.2 Parnell Business Overview
11.12.3 Parnell Companion Animals Medicines and Vaccines Introduction
11.12.4 Parnell Revenue in Companion Animals Medicines and Vaccines Business (2018-2024)
11.12.5 Parnell Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Medicines
Table 3. Key Players of Vaccines
Table 4. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Companion Animals Medicines and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Companion Animals Medicines and Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Companion Animals Medicines and Vaccines Market Share by Region (2018-2024)
Table 8. Global Companion Animals Medicines and Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Companion Animals Medicines and Vaccines Market Share by Region (2024-2029)
Table 10. Companion Animals Medicines and Vaccines Market Trends
Table 11. Companion Animals Medicines and Vaccines Market Drivers
Table 12. Companion Animals Medicines and Vaccines Market Challenges
Table 13. Companion Animals Medicines and Vaccines Market Restraints
Table 14. Global Companion Animals Medicines and Vaccines Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Companion Animals Medicines and Vaccines Revenue Share by Players (2018-2024)
Table 16. Global Top Companion Animals Medicines and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animals Medicines and Vaccines as of 2022)
Table 17. Global Companion Animals Medicines and Vaccines Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Companion Animals Medicines and Vaccines Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Companion Animals Medicines and Vaccines, Headquarters and Area Served
Table 20. Global Key Players of Companion Animals Medicines and Vaccines, Product and Application
Table 21. Global Key Players of Companion Animals Medicines and Vaccines, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Animals Medicines and Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2018-2024)
Table 25. Global Companion Animals Medicines and Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2024-2029)
Table 27. Global Companion Animals Medicines and Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Companion Animals Medicines and Vaccines Revenue Share by Application (2018-2024)
Table 29. Global Companion Animals Medicines and Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Companion Animals Medicines and Vaccines Revenue Share by Application (2024-2029)
Table 31. North America Companion Animals Medicines and Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Companion Animals Medicines and Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Companion Animals Medicines and Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Companion Animals Medicines and Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Companion Animals Medicines and Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Companion Animals Medicines and Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Companion Animals Medicines and Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Companion Animals Medicines and Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Companion Animals Medicines and Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Companion Animals Medicines and Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Companion Animals Medicines and Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Companion Animals Medicines and Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Companion Animals Medicines and Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Companion Animals Medicines and Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Companion Animals Medicines and Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Companion Animals Medicines and Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Companion Animals Medicines and Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Companion Animals Medicines and Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Companion Animals Medicines and Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Companion Animals Medicines and Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Companion Animals Medicines and Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Companion Animals Medicines and Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Companion Animals Medicines and Vaccines Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Companion Animals Medicines and Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Companion Animals Medicines and Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 63. Zoetis Company Details
Table 64. Zoetis Business Overview
Table 65. Zoetis Companion Animals Medicines and Vaccines Product
Table 66. Zoetis Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 67. Zoetis Recent Developments
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Companion Animals Medicines and Vaccines Product
Table 71. Boehringer Ingelheim Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Developments
Table 73. Merck Animal Health Company Details
Table 74. Merck Animal Health Business Overview
Table 75. Merck Animal Health Companion Animals Medicines and Vaccines Product
Table 76. Merck Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 77. Merck Animal Health Recent Developments
Table 78. Elanco Animal Health Company Details
Table 79. Elanco Animal Health Business Overview
Table 80. Elanco Animal Health Companion Animals Medicines and Vaccines Product
Table 81. Elanco Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 82. Elanco Animal Health Recent Developments
Table 83. Bayer Animal Health Company Details
Table 84. Bayer Animal Health Business Overview
Table 85. Bayer Animal Health Companion Animals Medicines and Vaccines Product
Table 86. Bayer Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 87. Bayer Animal Health Recent Developments
Table 88. Virbac Company Details
Table 89. Virbac Business Overview
Table 90. Virbac Companion Animals Medicines and Vaccines Product
Table 91. Virbac Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 92. Virbac Recent Developments
Table 93. Dechra Veterinary Products Company Details
Table 94. Dechra Veterinary Products Business Overview
Table 95. Dechra Veterinary Products Companion Animals Medicines and Vaccines Product
Table 96. Dechra Veterinary Products Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 97. Dechra Veterinary Products Recent Developments
Table 98. Ceva Company Details
Table 99. Ceva Business Overview
Table 100. Ceva Companion Animals Medicines and Vaccines Product
Table 101. Ceva Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 102. Ceva Recent Developments
Table 103. Vetoquinol Company Details
Table 104. Vetoquinol Business Overview
Table 105. Vetoquinol Companion Animals Medicines and Vaccines Product
Table 106. Vetoquinol Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 107. Vetoquinol Recent Developments
Table 108. Meiji Company Details
Table 109. Meiji Business Overview
Table 110. Meiji Companion Animals Medicines and Vaccines Product
Table 111. Meiji Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 112. Meiji Recent Developments
Table 113. Ouro Fino Saude Company Details
Table 114. Ouro Fino Saude Business Overview
Table 115. Ouro Fino Saude Companion Animals Medicines and Vaccines Product
Table 116. Ouro Fino Saude Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 117. Ouro Fino Saude Recent Developments
Table 118. Parnell Company Details
Table 119. Parnell Business Overview
Table 120. Parnell Companion Animals Medicines and Vaccines Product
Table 121. Parnell Revenue in Companion Animals Medicines and Vaccines Business (2018-2024) & (US$ Million)
Table 122. Parnell Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Companion Animals Medicines and Vaccines Market Share by Type: 2022 VS 2029
Figure 3. Medicines Features
Figure 4. Vaccines Features
Figure 5. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Companion Animals Medicines and Vaccines Market Share by Application: 2022 VS 2029
Figure 7. Dogs Case Studies
Figure 8. Cats Case Studies
Figure 9. Other Case Studies
Figure 10. Companion Animals Medicines and Vaccines Report Years Considered
Figure 11. Global Companion Animals Medicines and Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Companion Animals Medicines and Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Companion Animals Medicines and Vaccines Market Share by Region: 2022 VS 2029
Figure 14. Global Companion Animals Medicines and Vaccines Market Share by Players in 2022
Figure 15. Global Top Companion Animals Medicines and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animals Medicines and Vaccines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Companion Animals Medicines and Vaccines Revenue in 2022
Figure 17. North America Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
Figure 19. North America Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
Figure 20. North America Companion Animals Medicines and Vaccines Market Share by Country (2018-2029)
Figure 21. United States Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Companion Animals Medicines and Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
Figure 25. Europe Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
Figure 26. Europe Companion Animals Medicines and Vaccines Market Share by Country (2018-2029)
Figure 27. Germany Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Companion Animals Medicines and Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
Figure 35. China Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
Figure 36. Asia Companion Animals Medicines and Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
Figure 38. Asia Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
Figure 39. Asia Companion Animals Medicines and Vaccines Market Share by Region (2018-2029)
Figure 40. Japan Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Companion Animals Medicines and Vaccines Market Share by Country (2018-2029)
Figure 50. Brazil Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Companion Animals Medicines and Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Zoetis Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 58. Merck Animal Health Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 59. Elanco Animal Health Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 60. Bayer Animal Health Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 61. Virbac Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 62. Dechra Veterinary Products Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 63. Ceva Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 64. Vetoquinol Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 65. Meiji Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 66. Ouro Fino Saude Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 67. Parnell Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed